CAS 100299-08-9 Pemirolast potassium - Analytical Products / Alfa Chemistry

CAT	AP100299089
CAS	100299-08-9
Structure
Molecular Weight	266.30
InChI Key	NMMVKSMGBDRONO-UHFFFAOYSA-N

Description	≥98% (HPLC)
Solubility	H2O: ≥18 mg/mL
Assay	≥98% (HPLC)
Color	light yellow to green-yellow
Form	powder
Size	10MG, 50MG
Storage Conditions	2-8°C

1

Comparison of 0.1% Bromfenac Sodium and 0.1% Pemirolast Potassium for the Treatment of Allergic Conjunctivitis

Minori Miyake-Kashima, Yoji Takano, Mari Tanaka, Yoshiyuki Satake, Tetsuya Kawakita, Murat Dogru, Naoko Asano-Kato, Kazumi Fukagawa, Hiroshi Fujishima

Jpn J Ophthalmol. Nov-Dec 2004;48(6):587-90.

PMID: 15592786

1

Pemirolast Potassium 0.1% Ophthalmic Solution Is an Effective Treatment for Allergic Conjunctivitis: A Pooled Analysis of Two Prospective, Randomized, Double-Masked, Placebo-Controlled, Phase III Studies

Mark B Abelson, Gregg J Berdy, Thomas Mundorf, Lawrence D Amdahl, Adrienne L Graves, Pemirolast study group

J Ocul Pharmacol Ther. 2002 Oct;18(5):475-88.

PMID: 12419098

1

Preventive Effects of an Antiallergic Drug, Pemirolast Potassium, on Restenosis After Percutaneous Transluminal Coronary Angioplasty

H Ohsawa, H Noike, M Kanai, M Yoshinuma, K Mineoka, T Hitsumoto, K Aoyagi, T Sakurai, S Sato, T Uchi, K Kawamura, K Tokuhiro, Y Uchida, H Tomioka

Am Heart J. 1998 Dec;136(6):1081-7.

PMID: 9842024

1

Suppressive Activity of Pemirolast Potassium, an Antiallergic Drug, on Glomerulonephritis. Studies in Glomerulonephritis Model Rats and in Patients With Chronic Glomerulonephritis Concurrently Affected by Allergic Rhinitis

Tomohito Gohda, Chisei Ra, Chieko Hamada, Toshinao Tsuge, Hiroshi Kawachi, Yasuhiko Tomino

Arzneimittelforschung. 2008;58(1):18-23.

PMID: 18368946

1

Two Mast Cell Stabilizers, Pemirolast Potassium 0.1% and Nedocromil Sodium 2%, in the Treatment of Seasonal Allergic Conjunctivitis: A Comparative Study

David G Shulman

Adv Ther. Jan-Feb 2003;20(1):31-40.

PMID: 12772816

* Products or Services Interested: Pemirolast potassium (100299-08-9)
* Your question
* Name
* Email
Verification Code